Cumberland Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
CPIX Cumberland Pharmaceuticals Inc
GOL Gol Linhas Aereas Inteligentes SA
AAPL Apple Inc
JPM-L JPMorgan Chase & Co
BZFDW BuzzFeed Equity Warrant Exp 1st Dec 2026 *W EXP 12/01/2026
PANW Palo Alto Networks Inc
SIEGY Siemens AG
SLGL Sol Gel Technologies Ltd
AYRWF Ayr Wellness Inc
CTV Innovid Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that is focused on the acquisition, development, and commercialization of prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.

Postmarket

Last Trade
Delayed
$2.76
0.03 (1.10%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.73
Day's Change
-0.005 (-0.18%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
2.78
Day's Low
2.70
Volume
(Light)
Volume:
3,648

10-day average volume:
9,296
3,648

Company Profile

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company that is focused on the acquisition, development, and commercialization of prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
0.96x
Price/Book (MRQ)
1.02x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

January 2023
Current Month
21.1K
Previous Month
22.8K
Percent of Float
0.27%
Days to Cover
0.9788 Days

Share Information

CPIX is in a share class of common stock
Float
7.9M
Shares Outstanding
14.5M
Institutions Holding Shares
25
17.27%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • A. J. KazimiChmn.
  • John M. HammCFO
  • James L. HermanSr.VP
  • Martin S. BrownDir.
  • Gordon R. Bernard

Address

Insider Trading

During the most recent quarter, 30K shares were bought in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.